A Study to Learn How the Study Medicine (Ponsegromab) is Changed and Eliminated From Healthy Chinese Adults

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

January 18, 2023

Primary Completion Date

July 7, 2023

Study Completion Date

July 7, 2023

Conditions

Healthy

Interventions

DRUG

Ponsegromab

Participants will receive one subcutaneous injection

DRUG

Ponsegromab

Participants will receive four subcutaneous injections

Trial Locations (2)

Huashan Hospital Fudan University, Shanghai

HuaShan Hospital, Shanghai